Ideal Partner Company

KBL Merger Corp. IV was formed to acquire a profitable operating company in the healthcare and wellness space with attractive margins and substantial growth potential with a valuation of $200 – $700M. The management team and board of directors has decades of investing, operating and clinical expertise and most members have worked with KBL on prior SPACs, funds or portfolio companies.

Investment Criteria

To Avoid

  • FDA risk (i.e., pre-approval life sciences), hospitals or turn-around companies

Growth Potential

  • Significant historical and projected growth
  • Experienced management team
  • Scalable business model
  • Sustainable competitive advantage

Ownership

  • Private or sponsor-owned companies that would like to be public
  • A division or subsidiary of a parent company

Financial Profile

  • Profitable company with attractive margins
  • $20 – $70M in EBITDA, or lower where supported by public comparables
  • $200 – $700M in Enterprise Value

Select Sectors of Interest

Healthcare Services

Outpatient Care

Physician Practices

Behavioral Health

Payor Services

Pharma
Services

Outsourced Services

Contract Research

Generics / OTC

Health
IT

EMR / EHR

Rev. Cycle Mgmt.

Telemedicine

Care Management

Minimal
Reimbursement Risk

Retail Healthcare

Wellness

Preventative Care

Devices & Diagnostics

Medical Devices

Diagnostics

Genetic Testing

Lab Tools